Author:
Uchida Michihiko,Ho Dah Hsi W.,Kamiya Ken-ichi,Yoshimura Teruo,Sasaki Kin-ya,Tsutani Hiroshi,Nakamura Toru
Reference8 articles.
1. Ansfield, F.J., Schroeder, J.M., and Curreri, A.R. Five years clinical experience with 5-fluorouracil. J.A.M.A., 181:295–299 (1962).
2. Kanzawa, F., Hoshi, A., and Kuretani, K. Improvement of therapeutic effect of 5-fluorouracil by orotic acid. J. Pharm.Dyn., 2:257–259 (1979).
3. Byfield, J.E., Barone, R., Mendelsohn, J., Frankel, S., Quinol, L., Sharp, T., and Seagren, S. Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancer. Cancer, 45:703–708 (1980).
4. Speyer, J.L., Collins, J.M., Dedrick, R.L., Brennan, M.F., Buckpitt, A.R., Londer, H., Devita, Jr., V.T., and Myers, C.E. Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res., 40:567–572 (1980).
5. Gewirtz, A.M., and Canman, E. Preliminary Report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer, 47:2552–2555 (1981).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献